Skip to main content

Table 1 Baseline clinical characteristics of 43 patients with primary aldosteronism

From: Clinical outcomes of primary aldosteronism based on lateralization index and contralateral suppression index after adrenal venous sampling in real-world practice: a retrospective cohort study

Clinical parameters

N = 43

Age (range), (years)

48 (19–80)

Gender (Male/Female) (%)

17/26 (65.4/34.6)

Patients with hypertension (%)

40 (93.0)

Numbers of antihypertensives

3 (0–5)

Initial DDD

2.2 (0.0–4.8)

SBP (mmHg)

150 (110–204)

DBP (mmHg)

90 (63–160)

K (mEq/L)

3.2 (1.6–5.5)

PAC (ng/dL)

39.6 (27.0–227.2)

Plasma renin activity (ng/ml/h)

0.10 (0.10–2.4)

ARR

304.4 (34.5–1535.0)

Adrenal CT finding

 Unilateral adrenal mass (%)

32/43 (74.4)

 Bilateral hyperplasia or bilateral adenoma (%)

6/43 (14.0)

 No definite lesion (%)

5/43 (11.6)

 Size of adrenal mass (cm)

1.5 (0.0–7.3)

 Follow-up duration (months)

30.0 (12.6–86.0)

  1. Nonparametrically distributed data presented as median with range
  2. Frequencies and percentages were used for all categorical variables such as gender and CT findings
  3. DDD defined daily dose; SBP, systolic blood pressure, DBP diastolic blood pressure, K potassium, PAC plasma aldosterone concentration, ARR plasma aldosterone concentration/renin activity ratio, CT computed tomography